mTOR signaling promotes a robust and continuous production of IFN‐γ by human memory CD8+ T cells and their proliferation
Human CD8 + T cells are functionally heterogeneous and can be divided into phenotypically and functionally distinct subsets according to CCR7 and CD45RA expression levels. Among these, CCR7 low CD45RA low effector memory CD8 + T cells (Tem) and CCR7 low CD45RA high CD8 + T cells, which are designated as Temra and considered to be terminally differentiated cells, are Ag‐experienced T cells but show different functionalities. Here, we show that, while Tem proliferate vigorously and produce IFN‐γ persistently and robustly, Temra proliferate poorly and lose the ability to produce IFN‐γ over time after TCR stimulation. Temra showed impaired cell growth upon TCR stimulation, which was associated with defective activation of the mammalian target of rapamycin (mTOR) signaling. Furthermore, rapamycin, an inhibitor of mTOR signaling, interfered with the robust and continuous proliferation of and IFN‐γ production by Tem at later time points after TCR stimulation. Thus, these data collectively indicate that activation of mTOR signaling is required for the robust functions of Tem cells in humans and suggest that defective mTOR signaling in Temra contributes to their functional impairment..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
European journal of immunology - 45(2015), 3, Seite 893-902 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Setoguchi, Ruka [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1002/eji.201445086 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1962969037 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1962969037 | ||
| 003 | DE-627 | ||
| 005 | 20230714160427.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1002/eji.201445086 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1962969037 | ||
| 035 | |a (DE-599)GBVOLC1962969037 | ||
| 035 | |a (PRQ)p1261-c8f5623e0ae5caf6fcecb006afb5514abe524c206eeb8508c57879cdd6c2f25e3 | ||
| 035 | |a (KEY)0011453720150000045000300893mtorsignalingpromotesarobustandcontinuousproductio | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Setoguchi, Ruka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a mTOR signaling promotes a robust and continuous production of IFN‐γ by human memory CD8+ T cells and their proliferation |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Human CD8 + T cells are functionally heterogeneous and can be divided into phenotypically and functionally distinct subsets according to CCR7 and CD45RA expression levels. Among these, CCR7 low CD45RA low effector memory CD8 + T cells (Tem) and CCR7 low CD45RA high CD8 + T cells, which are designated as Temra and considered to be terminally differentiated cells, are Ag‐experienced T cells but show different functionalities. Here, we show that, while Tem proliferate vigorously and produce IFN‐γ persistently and robustly, Temra proliferate poorly and lose the ability to produce IFN‐γ over time after TCR stimulation. Temra showed impaired cell growth upon TCR stimulation, which was associated with defective activation of the mammalian target of rapamycin (mTOR) signaling. Furthermore, rapamycin, an inhibitor of mTOR signaling, interfered with the robust and continuous proliferation of and IFN‐γ production by Tem at later time points after TCR stimulation. Thus, these data collectively indicate that activation of mTOR signaling is required for the robust functions of Tem cells in humans and suggest that defective mTOR signaling in Temra contributes to their functional impairment. | ||
| 540 | |a Nutzungsrecht: © 2014 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim | ||
| 540 | |a © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. | ||
| 650 | 4 | |a CCR7 | |
| 650 | 4 | |a IFN‐γ | |
| 650 | 4 | |a CD45RA | |
| 650 | 4 | |a CD8 | |
| 650 | 4 | |a T cells | |
| 650 | 4 | |a mTOR signaling | |
| 650 | 4 | |a Signal Transduction - immunology | |
| 650 | 4 | |a Sirolimus - pharmacology | |
| 650 | 4 | |a Immunosuppressive Agents - pharmacology | |
| 650 | 4 | |a Antigens, CD45 - immunology | |
| 650 | 4 | |a CD8-Positive T-Lymphocytes - immunology | |
| 650 | 4 | |a Signal Transduction - drug effects | |
| 650 | 4 | |a Receptors, Antigen, T-Cell - immunology | |
| 650 | 4 | |a Receptors, CCR7 - immunology | |
| 650 | 4 | |a TOR Serine-Threonine Kinases - immunology | |
| 650 | 4 | |a Interferon-gamma - immunology | |
| 700 | 1 | |a Matsui, Yui |4 oth | |
| 700 | 1 | |a Mouri, Kousuke |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of immunology |d Weinheim : Wiley, 1971 |g 45(2015), 3, Seite 893-902 |w (DE-627)129288713 |w (DE-600)120108-6 |w (DE-576)014470306 |x 0014-2980 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2015 |g number:3 |g pages:893-902 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1002/eji.201445086 |3 Volltext |
| 856 | 4 | 2 | |u http://onlinelibrary.wiley.com/doi/10.1002/eji.201445086/abstract |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25476730 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_48 | ||
| 912 | |a GBV_ILN_267 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_2219 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2015 |e 3 |h 893-902 | ||